Firebrick Pharma Health Care
Biotech Healthcare Pharmaceuticals

$0.155 0.005 (3.33%)

High $0.16	Low $0.15	Trades 7	Turnover $4,468	Volume 29,243
30 June 2023 at 3:01pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code FRE	Name Firebrick Pharma Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 285,198,985	Shares Floated 141,908,894	Held by Insiders 45.437%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Dr. Peter Laurence Molloy B.Sc., F.A.C.I.D., M.B.A., Ph.D.	Founder, Executive Chairman & CEO
Dr. Stephen Francis Goodall M.B.A., Ph.D.	Founder, COO & Executive Director
Mr. Kavi Bekarma B.Sc., C.A.	Chief Financial Officer
Dr. Simon Tucker B.Sc., Ph.D.	Chief Scientific Officer
Dr. Monique Baldwin B.Sc., Ph.D.	Head of Regulatory Affairs
Mr. Nilesh N. Wadhwa	Head of Business Development & Licensing
Mr. Stephen Buckley	Company Secretary

FRE Historic Dividends

Date	Amount
We found no dividends on record for FRE.

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.03	59,878	0.00 (10.00%)
22-Jul	$0.03	0	0.00 (0.00%)
21-Jul	$0.03	73,698	0.00 (0.00%)
20-Jul	$0.03	87,766	+0.00 (7.14%)
17-Jul	$0.03	364,366	-0.04 (56.92%)
18-Sep	$0.07	86,441	0.00 (4.41%)
12-Sep	$0.07	9,012	+0.00 (4.62%)
11-Sep	$0.07	74,462	-0.01 (8.45%)
05-Sep	$0.07	135,388	0.00 (0.00%)
04-Sep	$0.07	157	0.00 (0.00%)
03-Sep	$0.07	13,158	0.00 (5.33%)
29-Aug	$0.08	0	0.00 (0.00%)
28-Aug	$0.08	0	0.00 (0.00%)
22-Aug	$0.08	174,657	0.00 (0.00%)
21-Aug	$0.08	317,245	-0.01 (6.25%)
2 up, 6 down, and 7 flat days

Market Cap (23-Jul) $7,700,372	EBITDA -	PE 0.00	Book Value $0.01
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -1320.03%	ROA 72.2%	ROE 142.7%	Revenue (FY) $410,699
Revenue per Share $0.00	Gross Profit (FY) $192,879	Q' YOY Revenue Growth 53.2%	Q' YOY Earnings Growth -

Firebrick Pharma Health Care
Biotech Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

FRE Historic Dividends

Followers

Prices

Announcements

End of Day Prices

FRE Firebrick Pharma Health Care Biotech Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

FRE Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Firebrick Pharma Health Care
Biotech Healthcare Pharmaceuticals